NEW
YORK, Sept. 12, 2023 /PRNewswire/ -- The Gross
Law Firm issues the following notice to shareholders of Syneos
Health, Inc..
Shareholders who purchased shares of SYNH during the class
period listed are encouraged to contact the firm regarding possible
lead plaintiff appointment. Appointment as lead plaintiff is not
required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/syneos-loss-submission-form/?id=47562&from=4
CLASS PERIOD: September 9,
2020 to November 3, 2022
ALLEGATIONS: The complaint alleges that
during the class period, Defendants issued materially false and/or
misleading statements and/or failed to disclose that: (a) Syneos's
business development capabilities had been materially impaired by
workforce reductions and leadership and operational changes, as
well as labor force turmoil caused by the COVID-19 pandemic; (b)
Syneos had struggled to integrate recent acquisitions, causing the
Company to suffer from a bloated and confused organizational
structure and impairing the Company's ability to provide
comprehensive or effective customer engagement across its product
portfolio; (c) Syneos was suffering from acute competitive
disadvantages as clinical trials moved to remote monitoring and
decentralized administration, as the Company lacked
the tools possessed by some of its rivals to successfully run
remote and decentralized trials, such as certain data
visualization and statistical modeling capabilities, and the
Company had failed to adapt to changing business demands in the
wake of the COVID-19 pandemic; (d) Syneos's backlog, book-to-bill
ratios, and net new business awards had been artificially inflated
by more than $500 million through the inclusion of reimbursable
expenses that the Company would never collect; (e) as a result of
(a)-(d) above, Syneos was struggling to execute on its existing
contracts and to agilely respond to its client needs, causing the
Company to suffer client dissatisfaction across its client base;
and (f) as a result of (a)-(e) above, Syneos was exposed to a
material undisclosed risk that the Company would lose customers, be
unable to grow its client base or win significant contract
renewals, and cede market share to its rivals.
DEADLINE: September 25,
2023 Shareholders should not delay in registering for
this class action. Register your information here:
https://securitiesclasslaw.com/securities/syneos-loss-submission-form/?id=47562&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a
shareholder who purchased shares of SYNH during the timeframe
listed above, you will be enrolled in a portfolio monitoring
software to provide you with status updates throughout the
lifecycle of the case. The deadline to seek to be a lead plaintiff
is September 25, 2023. There is no
cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally
recognized class action law firm, and our mission is to protect the
rights of all investors who have suffered as a result of deceit,
fraud, and illegal business practices. The Gross Law
Firm is committed to ensuring that companies adhere to responsible
business practices and engage in good corporate citizenship. The
firm seeks recovery on behalf of investors who incurred losses when
false and/or misleading statements or the omission of material
information by a company lead to artificial inflation of the
company's stock. Attorney advertising. Prior results do not
guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original
content:https://www.prnewswire.com/news-releases/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-syneos-health-inc-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-september-25-2023--nasdaq-synh-301924033.html
SOURCE The Gross Law Firm
